XNZE:XETRA:XETRA-Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 45.92

Change

-0.06 (-0.12)%

Market Cap

USD 0.02B

Volume

435.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.34 (+0.69%)

USD 509.68B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.12 (+0.76%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.86%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.10 (+0.37%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.12 (+0.51%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.72 (+1.21%)

USD 100.74B
JARI:XETRA Amundi Index Solutions - Amund..

+0.38 (+0.88%)

USD 100.71B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.38 (+0.77%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.70 (-0.13%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.19 (+0.87%)

USD 79.79B

ETFs Containing XNZE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.59% 61% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.59% 61% D- 61% D-
Trailing 12 Months  
Capital Gain 16.62% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.62% 62% D 63% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.50% 55% F 54% F
Dividend Return 5.50% 54% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.29% 72% C 78% C+
Risk Adjusted Return 75.42% 90% A- 90% A-
Market Capitalization 0.02B 12% F 11% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.